Mr Aubrey Glynn Moore, PHYSICIANS ASSISTANT | |
143 Hwy 32 Byp, Michael S. Deen M.d., Alma, GA 31510-2757 | |
(912) 632-8288 | |
(912) 632-3758 |
Full Name | Mr Aubrey Glynn Moore |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 143 Hwy 32 Byp, Alma, Georgia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598960080 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 001560PA (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Aubrey Glynn Moore, PHYSICIANS ASSISTANT 143 Hwy 32 Bypass, Michael S. Deen M.d.,p.c., Alma, GA 31510 Ph: (912) 632-8288 | Mr Aubrey Glynn Moore, PHYSICIANS ASSISTANT 143 Hwy 32 Byp, Michael S. Deen M.d., Alma, GA 31510-2757 Ph: (912) 632-8288 |
News Archive
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the enrollment of the first two patients in TRYTON-LM, a prospective, single-arm study evaluating the feasibility of the Tryton stent in conjunction with Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System to treat stable patients with complex de novo bifurcation lesions involving the left main coronary artery.
Bio-Trends is pleased to announce the publication of a new syndicated report, TreatmentTrendsĀ®: Rheumatoid Arthritis Q3 2010. This report covers the use of biologics for the treatment of rheumatoid arthritis (RA). The report, part of a quarterly series, focuses on current and future use of biologic agents, patient market share, perceived strengths and weaknesses of the key brands, barriers to broader usage, sales force performance and perceived value of manufacturers' patient assistance programs.
Invitae Corporation (NYSE: NVTA), a genetic information company, has announced that it has more than doubled the size of its genetic testing platform to include more than 600 genes and will begin releasing the new content between now and the end of the year. Invitae is immediately expanding its menu with dozens of new test panels for hereditary cancer, cardiovascular, neuromuscular, pediatric and other rare disorders.
Prolonged exposure to tiny particles of soot or dust found in traffic fumes and industrial emissions may be more deadly below current European Union air quality limits than previously thought, according to new research examining two decades of data from over 360 000 residents of large cities in 13 European countries.
The Food and Drug Administration may tighten restrictions on tanning beds "amid evidence they raise the risk of skin cancer beyond exposure to ultraviolet radiation from the sun," The Wall Street Journal reports.
› Verified 8 days ago
Michael S. Deen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 203 S Wayne St, Alma, GA 31510 Phone: 912-632-8288 Fax: 912-632-8458 | |
Dr. Ian Furtado, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 204 E 15th St, Alma, GA 31510 Phone: 912-632-2952 Fax: 912-632-8682 |